New developments in metastatic breast cancer: integrating recent data into clinical practice. Read more about New developments in metastatic breast cancer: integrating recent data into clinical practice.
New developments in metastatic breast cancer: general discussion. Read more about New developments in metastatic breast cancer: general discussion.
Ponatinib: targeting the T315I mutation in chronic myelogenous leukemia. Read more about Ponatinib: targeting the T315I mutation in chronic myelogenous leukemia.
Current treatment options for metastatic breast cancer: what now? Read more about Current treatment options for metastatic breast cancer: what now?
Clinical roundtable monograph. Current treatment options for metastatic breast cancer: what now? Read more about Clinical roundtable monograph. Current treatment options for metastatic breast cancer: what now?
New frontiers and treatment paradigms for metastatic breast cancer. A Review of an adjunct symposium of the 2011 American Society of Clinical Oncology Annual Meeting, June 4, 2011 Chicago, Illinois. Read more about New frontiers and treatment paradigms for metastatic breast cancer. A Review of an adjunct symposium of the 2011 American Society of Clinical Oncology Annual Meeting, June 4, 2011 Chicago, Illinois.
The relationship between symptomatology and treatment selection in metastatic castrate-resistant prostate cancer. Read more about The relationship between symptomatology and treatment selection in metastatic castrate-resistant prostate cancer.
The role of angiogenesis inhibition in the treatment of breast cancer. Read more about The role of angiogenesis inhibition in the treatment of breast cancer.
